Phil King’s Regal writes Opthea to zero and backs off risky bets
The veteran stockpicker told investors the firm would review how its $220 million wager on the biotech went so wrong “to ...
Health Check: FDA casualties mount as Trump’s ‘revolution’ takes place
Grisly tales are emerging from the corridors of the US Food & Drug Administration (FDA) as mass sackings  take effect.
PM, Dutton trade barbs; Star’s lifeline fails; Investors too calm
In today’s news, Anthony Albanese and Peter Dutton trade barbs over tariffs, Star turns to US casino giant Bally’s as a $750 million lifeline fails, and investors are too calm on Liberation Day’s eve.
HotCopper on MSN10hOpinion
Listen: HotCopper Podcast 008 – Take-off time... or is it more taxiing?
Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon ...
Market Index on MSN8h
Evening Wrap: ASX 200 rally stalls as mining and energy shares dumped ahead of Trump Liberation Day speech
The S&P/ASX 200 closed 9.3 points higher, up 0.12%. On surface, a quiet day for Aussie stocks. But this could not be further from the case! There were equally big winners and losers across the major ...
BioWorld21h
GRI soars on phase IIa IPF data with oral tazarotene
Shares of GRI Bio Inc. (NASDAQ:GRI) were trading at $6.28, up $3.08, or 96%, after the firm reported interim safety results from the ongoing phase IIa study testing GRI-0621 for idiopathic pulmonary ...
Explore more
A Rich Life13h
Our New ASX Investing Podcast: The ASX Small Cap Wrap
Podcast by Patrick Poke and Claude Walker covering the latest ASX small-cap investing news, with regular deep dives on ASX growth stocks.